Macquarie Group Ltd. raised its position in DuPont Co. (NYSE:DD) by 1.0% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,960,286 shares of the company’s stock after buying an additional 108,505 shares during the period. DuPont comprises 1.4% of Macquarie Group Ltd.’s portfolio, making the stock its 26th largest position. Macquarie Group Ltd. owned approximately 1.25% of DuPont worth $710,227,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Tarbox Group Inc. boosted its position in shares of DuPont by 0.3% in the second quarter. Tarbox Group Inc. now owns 3,645 shares of the company’s stock worth $236,000 after buying an additional 10 shares during the last quarter. Union Bankshares Corp boosted its position in shares of DuPont by 0.7% in the second quarter. Union Bankshares Corp now owns 4,497 shares of the company’s stock worth $291,000 after buying an additional 32 shares during the last quarter. Lourd Capital LLC boosted its position in shares of DuPont by 0.8% in the second quarter. Lourd Capital LLC now owns 4,184 shares of the company’s stock worth $271,000 after buying an additional 33 shares during the last quarter. Gerstein Fisher boosted its position in shares of DuPont by 1.1% in the second quarter. Gerstein Fisher now owns 5,178 shares of the company’s stock worth $336,000 after buying an additional 57 shares during the last quarter. Finally, Everett Harris & Co. CA boosted its position in shares of DuPont by 1.9% in the second quarter. Everett Harris & Co. CA now owns 3,219 shares of the company’s stock worth $209,000 after buying an additional 60 shares during the last quarter. 71.24% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for DuPont (NYSE:DD)

Shares of DuPont Co. (NYSE:DD) traded down 0.48% during mid-day trading on Friday, hitting $68.84. The company had a trading volume of 1,842,077 shares. The firm has a market capitalization of $59.85 billion, a PE ratio of 30.46 and a beta of 1.71. The firm has a 50-day moving average price of $68.66 and a 200-day moving average price of $67.56. DuPont Co. has a 52 week low of $50.71 and a 52 week high of $75.72.

DuPont (NYSE:DD) last posted its quarterly earnings data on Tuesday, October 25th. The company reported $0.34 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.21 by $0.13. The business had revenue of $4.90 billion for the quarter, compared to analysts’ expectations of $4.86 billion. DuPont had a return on equity of 27.16% and a net margin of 8.08%. The business’s revenue was up .9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.13 EPS. Equities analysts forecast that DuPont Co. will post $3.26 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 14th. Shareholders of record on Tuesday, November 15th will be given a dividend of $0.38 per share. The ex-dividend date of this dividend is Thursday, November 10th. This represents a $1.52 annualized dividend and a yield of 2.21%. DuPont’s payout ratio is 67.26%.

Several equities research analysts have recently weighed in on the company. Zacks Investment Research cut DuPont from a “buy” rating to a “hold” rating in a research note on Tuesday, September 27th. Citigroup Inc. raised DuPont from a “neutral” rating to a “buy” rating and increased their price target for the company from $72.00 to $76.00 in a research note on Monday, October 3rd. Nomura assumed coverage on DuPont in a research note on Tuesday, October 18th. They issued a “buy” rating and a $78.00 price target for the company. Vetr cut DuPont from a “sell” rating to a “strong sell” rating and set a $61.16 price target for the company. in a research note on Monday, July 25th. Finally, Barclays PLC increased their price target on DuPont from $67.00 to $70.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 27th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the stock. DuPont has a consensus rating of “Hold” and a consensus price target of $71.15.

In other DuPont news, EVP Christopher Marc Doyle sold 5,422 shares of DuPont stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $69.53, for a total transaction of $376,991.66. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Benito Cachinero sold 58,958 shares of DuPont stock in a transaction that occurred on Wednesday, August 24th. The shares were sold at an average price of $70.36, for a total value of $4,148,284.88. The disclosure for this sale can be found here. Company insiders own 0.31% of the company’s stock.

DuPont Company Profile

E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company consists of over 10 businesses aggregated into six segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Its products include corn hybrids and soybean varieties, herbicides, fungicides and insecticides in Agriculture segment; photopolymers and electronic materials in Electronics & Communications segment; enzymes and bio-based materials in Industrial Biosciences segment; cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients in Nutrition & Health segment; engineering polymers, packaging and industrial polymers, films and elastomers in Performance Materials segment, and nonwovens, aramids and solid surfaces in Safety & Protection segment.

5 Day Chart for NYSE:DD

Receive News & Stock Ratings for DuPont Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont Co. and related stocks with our FREE daily email newsletter.